Author:
Tsai H.-T.,Marshall J.L.,Weiss S.R.,Huang C.-Y.,Warren J.L.,Freedman A.N.,Fu A.Z.,Sansbury L.B.,Potosky A.L.
Funder
National Institutes of Health
Reference33 articles.
1. WHO. http://globocan.iarc.fr/factsheets/cancers/colorectal.asp 2011 (14 December 2012, date last accessed)
2. Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on US cancer burden;Edwards;. Cancer,2002
3. Randomized phase III trial results of panitumumab, a fully human anti-epidermal growth factor receptor monoclonal antibody, in metastatic colorectal cancer;Gibson;Clin Colorectal Cancer,2006
4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004
5. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor;Saltz;J Clin Oncol,2004
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献